Latest Breaking News On - Spliceopathy improvement - Page 1 : comparemela.com

SAN DIEGO, Aug. 31, 2023 /PRNewswire/ Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates ,.

United statesSan diegoMike macleanNavjot raiAvidity biosciences incPrnewswire avidity biosciences incMyotonic dystrophy foundation annual conferenceAntibody oligonucleotide conjugatesDystrophy foundation annual conferenceSpliceopathy improvementMyotonic dystrophy typeData analysisTrial evaluatingAdult patientsOligonucleotide conjugates